Drugmaker Aurobindo Pharma Ltd has received US regulatory approval to manufacture and market Alendronate Sodium tablets, in variants of 10 mg, 35 mg and 70 mg.
 
Alendronate Sodium tablets, used in the treatment of Osteoporosis, are generic equivalent to Merck & Co's Inc Fosamax tablets.

This has been one of fastest approvals received by the company, within 8 months of the date of filing. With this, the number of Abbreviated New Drug Application (ANDA) approvals from the US FDA stands at 73.